Cryo-ablation improves anti-tumor immunity through recovering tumor educated dendritic cells in tumor-draining lymph nodes

被引:16
|
作者
He, Xiao-Zheng [1 ,2 ]
Wang, Qi-Fu [1 ,2 ]
Han, Shuai [3 ]
Wang, Hui-Qing [1 ,2 ]
Ye, Yong-Yi [1 ,2 ]
Zhu, Zhi-Yuan [1 ,2 ]
Zhang, Shi-Zhong [1 ,2 ]
机构
[1] Southern Med Univ, Zhujiang Hosp, Dept Neurosurg, Guangzhou 510282, Guangdong, Peoples R China
[2] Southern Med Univ, Neurosurg Inst Guangdong Prov, Natl Key Clin Specialty, Guangdong Prov Key Lab Brain Funct Repair & Regen, Guangzhou 510282, Guangdong, Peoples R China
[3] Southern Med Univ, Zhujiang Hosp, Dept Gen Surg, Guangzhou 510282, Guangdong, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
glioma; cryo-ablation; dendritic cells; tumor-draining lymph nodes; anti-tumor immunity; REGULATORY T-CELLS; CANCER-IMMUNOTHERAPY; ANTIGEN; EXPRESSION; INDUCTION; GLIOMAS; CRYOABLATION; MACROPHAGES; COMBINATION; TOLERANCE;
D O I
10.2147/DDDT.S76592
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Background: In addition to minimally invasive destruction of tumors, cryo-ablation of tumors to some extent modulated anti-tumor immunity. Cryo-ablated tumors in glioma mice models induced anti-tumor cellular immunologic response which increases the percentage of CD3(+) and CD4(+)T cells in blood as well as natural killer cells. As a crucial role in triggering anti-tumor immunity, dendritic cells (DCs) were educated by tumors to adopt a tolerance phenotype which helps the tumor escape from immune monitoring. This study aims to study whether cryo-ablation could influence the tolerogenic DCs, and influence anti-tumor immunity in tumor-draining lymph nodes (TDLNs). Methods: Using the GL261 subcutaneous glioma mouse model, we created a tumor bearing group, cryo-ablation group, and surgery group. We analyzed alteration in phenotype and function of tolerogenic DCs, and evaluated the factors of anti-tumor immunity inhibition. Results: DCs in TDLNs in GL261 subcutaneous glioma mouse model expressed tolerogenic phenotype. In contrast to surgery, cryo-ablation improved the quantity and quality of these tolerogenic DCs. Moreover, the DCs decreased the expression of intracellular interleukin-10 (IL-10) and extra-cellular IL-10. In vitro, DCs from the cryo-ablation group recovered their specific function and induced potent anti-tumor immunity through triggering T cells. In vivo, cryo-ablation showed weak anti-tumor immunity, only inhibiting the growth of rechallenged tumors. But many IL-10-low DCs, rather than IL-10-high DCs, infiltrated the tumors. More importantly, Tregs inhibited the performance of these DCs; and depletion of Tregs greatly improved anti-tumor immunity in vivo. Conclusion: Cryo-ablation could recover function of tumor induced tolerogenic DCs in vitro; and depletion of Tregs could improve this anti-tumor effect in vivo. The Tregs/CD4(+)T and Tregs/CD25(+)T cells in TDLNs inhibit DCs' activity and function.
引用
收藏
页码:1449 / 1458
页数:10
相关论文
共 50 条
  • [1] Dendritic cells dysfunction in tumor-draining lymph nodes
    Bandola-Simon, Joanna Marta
    Roche, Paul A.
    [J]. JOURNAL OF IMMUNOLOGY, 2021, 206
  • [2] Dendritic cells dysfunction in tumor-draining lymph nodes
    Bandola-Simon, Joanna Marta
    Roche, Paul A.
    [J]. JOURNAL OF IMMUNOLOGY, 2019, 202 (01):
  • [3] Dendritic cells dysfunction in tumor-draining lymph nodes
    Bandola-Simon, Joanna Marta
    Wong, Nathan
    Cam, Maggie
    Roche, Paul A.
    [J]. JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [4] Dysfunction of Dendritic CeLLs in Tumor-Draining Lymph Nodes
    Marta Bandola-Simon, Joanna
    Roche, Paul A.
    [J]. JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
  • [5] Tumor-draining lymph nodes: At the crossroads of metastasis and immunity
    du Bois, Haley
    Heim, Taylor A.
    Lund, Amanda W.
    [J]. SCIENCE IMMUNOLOGY, 2021, 6 (63)
  • [6] Invariant natural killer T cells regulate anti-tumor immunity by controlling the population of dendritic cells in tumor and draining lymph nodes
    Pilones, Karsten A.
    Aryankalayil, Joseph
    Babb, James S.
    Demaria, Sandra
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2014, 2
  • [7] Interrogating BDCA3+dendritic cells in human tumor-draining lymph nodes
    van de Ven, Rieneke
    Haley, Daniel
    Walker, Edwin
    Fountain, Christopher
    Douglas, Jeremy
    Wood, William
    Yu, Kelvin
    Aliabadi, Shaghayegh
    Fox, Bernard
    Hu, Hong Ming
    de Gruijl, Tanja
    Urba, Walter
    [J]. JOURNAL OF IMMUNOLOGY, 2012, 188
  • [8] Coimmunomodulation of tumor and tumor-draining lymph nodes during in situ vaccination promotes antitumor immunity
    Jeong, Moonkyoung
    Kim, Heegon
    Yoon, Junyong
    Kim, Dong-Hyun
    Park, Ji-Ho
    [J]. JCI INSIGHT, 2022, 7 (12)
  • [9] SUPPRESSOR CELLS IN HUMAN TUMOR-DRAINING LYMPH-NODES
    HOON, DB
    BOWKER, R
    COCHRAN, AJ
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 286 - 286
  • [10] Sampling tumor-draining lymph nodes for phenotypic and functional analysis of dendritic cells and T cells
    Vuylsteke, RJCLM
    van Leeuwen, PAM
    Meijer, S
    Wijnands, PGJTB
    Muller, MGS
    Busch, DH
    Scheper, RJ
    de Gruijl, TD
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (01): : 19 - 26